# Exxonmobil Product Solutions Company - Inspection Records Source: https://www.keypedia.com/companies/exxonmobil-product-solutions-company/8e83c4a4-cc31-4bfd-abc9-d6f2df29259f > Inspection records and compliance data for Exxonmobil Product Solutions Company in Baton Rouge, LA. Access full analysis and detailed observations. --- ## Details - Name: Exxonmobil Product Solutions Company - FEI Number: 2313361 - City: Baton Rouge - State: LA - Country Name: United States - Address Line 1: 4999 Scenic Hwy - Zip Code: 70805-3359 - Business Operations: API MANUFACTURE ## Related Documents - [483 - Exxonmobil Product Solutions Company - 2025-12-11](https://www.keypedia.com/records/483/exxonmobil-product-solutions-company/6260797e-3f8f-4f4d-b8fc-691b5763e5aa) — source: FDA, date: December 11, 2025 - [FDA Inspection 1299690 - Exxonmobil Product Solutions Company - 2025-12-11](https://www.keypedia.com/records/fda_inspections/exxonmobil-product-solutions-company/379515cf-6950-4f69-978d-49b6512752ad) — source: FDA, date: December 11, 2025 - [FDA Inspection 1299690 - Exxonmobil Product Solutions Company - 2025-12-11](https://www.keypedia.com/records/fda_inspections/exxonmobil-product-solutions-company/33ef8115-f694-48ba-a484-20373a0b90a4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 11, 2025 - [EIR - Exxonmobil Product Solutions Company - 2019-12-11](https://www.keypedia.com/records/eir/exxonmobil-product-solutions-company/6fdfc4e2-9e5c-4f04-9b65-b62c17d9e454) — source: FDA, date: December 11, 2019 - [FDA Inspection 1116384 - Exxonmobil Product Solutions Company - 2019-12-11](https://www.keypedia.com/records/fda_inspections/exxonmobil-product-solutions-company/9c4c03af-e29c-405f-be31-25ed2d2537a2) — classification: No Action Indicated (NAI), source: FDA, date: December 11, 2019 - [EIR - Exxonmobil Product Solutions Company - 2018-03-09](https://www.keypedia.com/records/eir/exxonmobil-product-solutions-company/d0ed0a1b-1752-41a6-a17a-10d99b4eb8db) — source: FDA, date: March 9, 2018 - [FDA Inspection 1044898 - Exxonmobil Product Solutions Company - 2018-03-09](https://www.keypedia.com/records/fda_inspections/exxonmobil-product-solutions-company/1d3f7c78-17a3-4302-934d-ad62b069a72c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 9, 2018 - [FDA Inspection 1044898 - Exxonmobil Product Solutions Company - 2018-03-09](https://www.keypedia.com/records/fda_inspections/exxonmobil-product-solutions-company/dcc239c5-0a6d-4af7-a3a1-48caed014a3f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 9, 2018 - [EIR - Exxonmobil Product Solutions Company - 2016-04-21](https://www.keypedia.com/records/eir/exxonmobil-product-solutions-company/88fed02e-9e74-4007-b291-41937d05ce7e) — source: FDA, date: April 21, 2016 - [FDA Inspection 979492 - Exxonmobil Product Solutions Company - 2016-04-21](https://www.keypedia.com/records/fda_inspections/exxonmobil-product-solutions-company/35e6a437-c211-400d-9b5f-f9863dbbcc00) — classification: No Action Indicated (NAI), source: FDA, date: April 21, 2016 - [FDA Inspection 979492 - Exxonmobil Product Solutions Company - 2016-04-21](https://www.keypedia.com/records/fda_inspections/exxonmobil-product-solutions-company/59a376d6-51f8-416d-b6b6-180a24616017) — classification: No Action Indicated (NAI), source: FDA, date: April 21, 2016 - [EIR - Exxonmobil Product Solutions Company - 2013-03-21](https://www.keypedia.com/records/eir/exxonmobil-product-solutions-company/53416370-c6bc-4e98-ac79-1b0ea273f2c5) — source: FDA, date: March 21, 2013 - [FDA Inspection 824219 - Exxonmobil Product Solutions Company - 2013-03-21](https://www.keypedia.com/records/fda_inspections/exxonmobil-product-solutions-company/46c987f7-b9e9-42f7-8cb7-e488b27fdcdb) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 21, 2013 - [FDA Inspection 614653 - Exxonmobil Product Solutions Company - 2009-09-17](https://www.keypedia.com/records/fda_inspections/exxonmobil-product-solutions-company/26374f76-b348-4eb5-915e-2bf1944e930b) — classification: No Action Indicated (NAI), source: FDA, date: September 17, 2009 ## Related Companies - [Sonneborn, LLC](https://www.keypedia.com/companies/sonneborn-llc/a3b94b8f-4ffb-4c19-9bb5-b8cfc23c7f58) - [US Specialty Formulations LLC](https://www.keypedia.com/companies/us-specialty-formulations-llc/2a5dd57a-6a0b-44a4-88ec-d642f91d1315) - [Hetero Drugs Ltd. - Unit 1](https://www.keypedia.com/companies/hetero-drugs-ltd-unit-1/4c15935a-9ff7-4f66-b649-3d78aa3e9753) - [Smithfield Bioscience Inc](https://www.keypedia.com/companies/smithfield-bioscience-inc/f87613b8-a59a-4a6d-b412-9f2b145f397b) - [Sri Krishna Pharmaceuticals Limited - Unit IV](https://www.keypedia.com/companies/sri-krishna-pharmaceuticals-limited-unit-iv/fd405e8b-b747-4adb-bbb5-da63c0cfa56b) - [Novo Nordisk US Bio Production Inc.](https://www.keypedia.com/companies/novo-nordisk-us-bio-production-inc/08f5214b-4db0-4d94-86ee-4ba9c3c28ea2) - [Grant Industries, Inc.](https://www.keypedia.com/companies/grant-industries-inc/bf60053c-0aa3-4217-b068-ef8b06b6bd27) - [Pharmazell (India) Private Ltd](https://www.keypedia.com/companies/pharmazell-india-private-ltd/1a60e2bc-b058-468d-b52f-ba85d9f757d2) - [Zhejiang Haisen Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/zhejiang-haisen-pharmaceutical-co-ltd/2d2c27d1-770f-4367-a180-92298e925ab8) - [SRI Krishna Pharmaceuticals Ltd - Unit I](https://www.keypedia.com/companies/sri-krishna-pharmaceuticals-ltd-unit-i/a8609781-dc13-4ad6-9bb3-047ead2bf151) ## Related Officers - [company_representative](https://www.keypedia.com/people/stephen-j-hamilton/33cd11e0-75e7-4250-8d1d-168e83285ec2) - [recipient](https://www.keypedia.com/people/john-m-kovich/3dfb2d73-7cea-4afa-966e-92d4cecacee9) - [Investigator](https://www.keypedia.com/people/marvin-d-jones/3101a8da-f5c1-4e0c-b4b1-b09be181be36) - [recipient](https://www.keypedia.com/people/james-t-ritchie/5c1dbade-ecb5-4dc8-b8a2-0a6676dd0a43) - [Jennifer L. Huntington](https://www.keypedia.com/people/jennifer-l-huntington/c04e1c86-c7ec-4613-b3f7-a1f9ba2b2f2c)